Form D · Biotechnology
VASCULAR THERAPIES INC
Cresskill, NJ · CIK 0001342710
Offering snapshot reported Mar 4, 2022 · SEC filing
- Reported sold
- $24M Offering amount: $25.2M
- Investors reported
- 54 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 18, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2022 | Initial | $23,963,442 | No comparison | 54 | SEC filing |
| Aug 27, 2021 | Initial | $3,748,712 | No comparison | Not reported | SEC filing |
| Nov 21, 2019 | Initial | $7,382,500 | No comparison | 39 | SEC filing |
| Oct 12, 2018 | Initial | $12,360,000 | No comparison | 29 | SEC filing |
| Dec 30, 2016 | Amendment | $31,000,000 | $14,800,000vs Feb 19, 2015 | 33 | SEC filing |
| Feb 19, 2015 | Initial | $16,200,000 | No comparison | 30 | SEC filing |
| Jul 12, 2013 | Amendment | $5,195,226 | $2,695,227vs Jul 13, 2012 | 11 | SEC filing |
| Jul 13, 2012 | Initial | $2,499,999 | No comparison | 1 | SEC filing |
| Jun 14, 2011 | Initial | $3,159,325 | No comparison | 30 | SEC filing |
| Apr 25, 2011 | Initial | $348,000 | No comparison | 16 | SEC filing |
| Apr 25, 2011 | Initial | $1,375,000 | No comparison | 22 | SEC filing |
| Apr 25, 2011 | Initial | $646,340 | No comparison | 23 | SEC filing |
| Oct 25, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-435950
Source: Form D, filed Mar 4, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Bamberger | Director |
| Paul Barkofsky | Director |
| Robert Croce | Director |
| Gerald Dorros | Director |
| Robert Flanagan | Director |
| Sriram Iyer | Director, Executive |
| Samuel M. Liang | Director |
| John Mc Dermott | Director, Executive |
| Andrew Midler | Director |
| Daniel Ryan | Director |
| Dan Ryan | Director |
| Somus Subramaniam | Director |
| Somu Subramaniam | Director |
| Kiyoshi Takesue | Director |
| Allan Tessler | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
105 Union Avenue
Cresskill, NJ, 07626
Cresskill, NJ, 07626